Activity of N,N-dimethy-1-2-propen-1-amine derivatives in mice experimentally infected with Trypanosoma cruzi

Acta Tropica

Volumn 69, Issue 3, 1998, Pages 205-211

  Pereira, Dárcio G ^a   De Castro, Solange L ^b   Durán, Nelson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

2 Propen 1 amines; Chemotherapy; In vivo studies; Trypanosoma cruzi

Indexed keywords

3 (4' BROMO [1,1' BIPHENYL] 4 YL) 3 (4 BROMOPHENYL) N,N DIMETHYL 2 PROPEN 1 AMINE; 3 (4' BROMO [1,1' BIPHENYL] 4 YL) 3 PHENYL) N,N DIMETHYL 2 PROPEN 1 AMINE; ANTIPROTOZOAL AGENT; N,N DIMETHY1 1-2 PROPEN 1 AMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ACTIVITY; MALE; MORTALITY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITEMIA; STRUCTURE ACTIVITY RELATION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ALLYLAMINE; ANIMALS; BIPHENYL COMPOUNDS; CHAGAS DISEASE; MALE; MICE; PARASITEMIA; TRYPANOCIDAL AGENTS;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0031748165     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(97)00127-7     Document Type: Article

References (21)

1. Babich H., Borenfreund J.A. Applications of the neutral red cytotoxicity assay to in vitro toxicology. ATLA. 18:1990;129-144.
2. Barrett, P.A., 1976. 3-amino-prop-1-ene, methods for their preparation. The Patent Office London, patent number 1 434 714.
3. Barrett P.A., Beveridge E., Bull D. et al. The efficacy of a novel compound, (E)-1-(4′-bromo-4-biphenylyl)-1-(4-chlorophenyl)-3-dimethylaminoprop-1-ene against Trypanosoma cruzi in mice. Experientia. 38:1982;338-339.
4. Brener Z. Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the Western Hemisphere. Pharmacol. Ther. 7:1979;71-90.
5. Castro Silva R., Santiago C.M.G., Lima Pontes A., Andrade S.G. Padrão isoenzimático da cepa Y do Trypanosoma cruzi após quimioterapia específica. Mem. Inst. Oswaldo Cruz. 84:1989;81-86.
6. De Andrade A.L.S.S., Zicker F., de Oliveira R.M. et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet. 348:1996;1407-1413.
7. De Castro S.L. The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruzi. Acta Trop. 53:1993;83-98.
8. De Conti, R., 1996. Synthesis and biological activities of N,N-dimethyl-2-propen-1-amine derivatives. Ph.D. Thesis, Instituto de Química, UNICAMP, Campinas, Brazil.
9. De Conti R., Gimenez S.M.N., Haun M., Pilli R.A., De Castro S.L., Durán N. Synthesis and biological activities of N,N-dimethyl-2-propen-1-amine derivatives. Eur. J. Med. Chem. 31:1996a;915-918.
10. De Conti R., Santa Rita R.M., de Souza E.M. et al. In vitro trypanocidal activities of a novel series of N,N-dimethyl-2-propen-1-amine derivative. Microbios. 85:1996b;83-87.
11. Doyle P.S., Weinbach E.C. The activity of tricyclic antidepressant drugs against Trypanosoma cruzi. Exp. Parasitol. 68:1989;230-234.
12. Durán N., Haun M. Trypanocides: State of art. Mem. Inst. Oswaldo Cruz. 86(1):1991;29-30.
13. Fernandes, A.M.P., 1997. Synthesis, characterization and evaluation of isomeric mixture of 3-(4′-bromo-[1,1′-biphenyl]-4-yl)-3-(4-bromophenyl)-N,N-dimethyl-2- propen-1-amine and its geometrical isomers. M. Sc. Thesis, Instituto de Química, UNICAMP, Campinas, Brazil.
14. Fernandes, A.M.P., Oliveira, D.A., Rodriguez, J.A., Melo, P.S., De Conti, R., Haun, M., Souza-Brito, A.R.M., De Castro S.L., Durán, N., 1997. In: Caxambu, M.G. (Ed.), 2-Propen-1-amine geometrical isomers: trypanocidal activities and toxicity's. XXIV Ann. Meeting on Basic Res. in Chagas' disease, Brazil.
15. Hammond D.J., Cover B., Gutteridge W.E. A novel series of chemical structures active in vitro against the trypomastigote form of Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 78:1984;91-95.
16. Lüllmann H., Lüllmann-Rauch R., Wassermann O. Lipidosis induced by amphiphilic cationic drugs. Biochem. Pharmacol. 27:1978;1103-1108.
17. Michell R.H., Allan D., Bowley M., Brindley D.N. A possible metabolic explanation for drug-induced phospholipidosis. J. Pharm. Pharmacol. 28:1976;331-332.
18. Moncayo, A., 1993. Chagas' disease. Tropical Disease Report - Progress 1991-1992. 11th Progr. Report UNDP/World Bank/WHP Special Program for Training in Tropical Diseases, WHO, Geneva.
19. Neal R.A., van Bueren J. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro. Trans. R. Soc. Trop. Med. Hyg. 82:1988;709-714.
20. Oliveira D.A., De Conti R., Santa-Rita R.M., De Castro S.L., Haun M., Durán N. Selectivity in the trypanocidal activity of N,N-dimethyl-2-propen-1-amine isomers. Mem. Inst. Oswaldo Cruz. 91:1996;320.
21. Silva L.H.P., Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta pare o camundongo branco. Folia Clin. Biol. 20:1953;191-207.